Neuberger Berman Group LLC Cytokinetics Inc Transaction History
Neuberger Berman Group LLC
- $124 Billion
- Q2 2025
A detailed history of Neuberger Berman Group LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 6,177 shares of CYTK stock, worth $384,518. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,177
Previous 6,177
-0.0%
Holding current value
$384,518
Previous $204,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CYTK
# of Institutions
384Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.1 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$913 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$746 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$487 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$397 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.86B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...